JP2005508959A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508959A5 JP2005508959A5 JP2003535782A JP2003535782A JP2005508959A5 JP 2005508959 A5 JP2005508959 A5 JP 2005508959A5 JP 2003535782 A JP2003535782 A JP 2003535782A JP 2003535782 A JP2003535782 A JP 2003535782A JP 2005508959 A5 JP2005508959 A5 JP 2005508959A5
- Authority
- JP
- Japan
- Prior art keywords
- mycophenolic acid
- tablet
- enteric
- mycophenolate
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0124953.1A GB0124953D0 (en) | 2001-10-17 | 2001-10-17 | Organic Compounds |
| GB0124953.1 | 2001-10-17 | ||
| PCT/EP2002/011589 WO2003032978A1 (en) | 2001-10-17 | 2002-10-16 | Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009012781A Division JP2009137996A (ja) | 2001-10-17 | 2009-01-23 | ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508959A JP2005508959A (ja) | 2005-04-07 |
| JP2005508959A5 true JP2005508959A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
Family
ID=9924043
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003535782A Pending JP2005508959A (ja) | 2001-10-17 | 2002-10-16 | ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物 |
| JP2009012781A Pending JP2009137996A (ja) | 2001-10-17 | 2009-01-23 | ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009012781A Pending JP2009137996A (ja) | 2001-10-17 | 2009-01-23 | ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物 |
Country Status (31)
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0124953D0 (en) | 2001-10-17 | 2001-12-05 | Novartis Ag | Organic Compounds |
| AR045957A1 (es) * | 2003-10-03 | 2005-11-16 | Novartis Ag | Composicion farmaceutica y combinacion |
| WO2006012379A2 (en) * | 2004-07-20 | 2006-02-02 | Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg | Processes for preparation of crystalline mycophenolate sodium |
| GB0419355D0 (en) * | 2004-08-31 | 2004-09-29 | Novartis Ag | Organic compounds |
| EP1917010A2 (en) * | 2005-02-08 | 2008-05-07 | Aspreva Pharmaceuticals SA | Compositions and methods for treating vascular, autoimmune and inflammatory diseases |
| WO2006086498A2 (en) | 2005-02-08 | 2006-08-17 | Aspreva Pharmaceuticals Sa | Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors |
| BRPI0616640A2 (pt) * | 2005-09-30 | 2011-06-28 | Novartis Ag | combinação de compostos orgánicos |
| EP1965760B1 (de) | 2005-12-21 | 2013-02-27 | Basf Se | Feinteiliges quervernetztes polyvinylpyrrolidon als tablettensprengmittel |
| CN101378749A (zh) * | 2006-02-13 | 2009-03-04 | 诺瓦提斯公司 | 高剂量的麦考酚酸(mpa) |
| US10406105B2 (en) | 2007-06-06 | 2019-09-10 | Basf Se | Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| US8568780B2 (en) | 2007-06-06 | 2013-10-29 | Basf Se | Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| AU2008288106B2 (en) * | 2007-08-13 | 2012-03-15 | Panacea Biotec Limited | Extended release compositions comprising mycophenolate sodium and processes thereof |
| JP2011513391A (ja) * | 2008-03-05 | 2011-04-28 | パナセア バイオテック リミテッド | ミコフェノラートを含有する徐放性医薬組成物およびその方法 |
| CA2729834A1 (en) * | 2008-07-09 | 2010-01-14 | Aspreva International Ltd. | Formulations for treating eye disorders |
| WO2011046546A1 (en) * | 2009-10-13 | 2011-04-21 | Teva Pharmaceutical Industries Ltd. | Delayed release compositions |
| US20110086102A1 (en) * | 2009-10-13 | 2011-04-14 | Teva Pharmaceutical Industries Ltd. | Delayed release compositions |
| WO2011051967A2 (en) * | 2009-10-23 | 2011-05-05 | Alkem Laboratories Ltd | Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof |
| GB201100786D0 (en) | 2011-01-18 | 2011-03-02 | Ems Sa | Pharmaceutical compositions of immunosuppressants |
| CN102793658A (zh) * | 2012-08-23 | 2012-11-28 | 无锡福祈制药有限公司 | 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片 |
| CN103845323B (zh) * | 2012-11-30 | 2018-02-02 | 重庆华邦制药有限公司 | 麦考酚酸及其盐肠溶制剂和制备方法 |
| WO2014167442A1 (en) | 2013-03-26 | 2014-10-16 | Wockhardt Limited | Pharmaceutical compositions comprising mycophenolic acid or salts thereof |
| CN106727403A (zh) * | 2017-01-03 | 2017-05-31 | 无锡福祈制药有限公司 | 一种麦考酚钠肠溶片及其制备方法 |
| US11633378B2 (en) * | 2017-03-13 | 2023-04-25 | Okava Pharmaceuticals, Inc. | Methods and compositions for delivering mycophenolic acid active agents to non-human mammals |
| SG11202007172YA (en) | 2018-06-06 | 2020-08-28 | Metavant Sciences Gmbh | Methods of treating subjects having diabetes with chronic kidney disease |
| JP7266616B2 (ja) * | 2018-06-14 | 2023-04-28 | ポクセル | 糖尿病の治療において使用するためのトリアジン誘導体を含むフィルムコーティング錠剤 |
| RU2723255C2 (ru) * | 2018-11-14 | 2020-06-09 | Общество с ограниченной ответственностью "Изварино Фарма" | Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы |
| MX2023008907A (es) * | 2021-01-28 | 2023-08-09 | Priothera Sas | Metodos de tratamiento con moduladores del receptor de esfingosina-1-fosfato (s1p). |
| US20240261218A1 (en) * | 2021-05-26 | 2024-08-08 | The Texas A&M University System | Biodegradable mucoadhesive pharmaceutical formulations and methods thereof |
| CN117442580B (zh) * | 2023-12-21 | 2024-04-05 | 泊诺(天津)创新医药研究有限公司 | 一种高生物利用度麦考酚钠肠溶片及其制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1157100A (en) † | 1966-09-27 | 1969-07-02 | Ici Ltd | Pharmaceutical Compositions |
| GB1157099A (en) * | 1966-09-27 | 1969-07-02 | Ici Ltd | Fermentation Process |
| GB1203328A (en) * | 1968-06-04 | 1970-08-26 | Ici Ltd | Pharmaceutical compositions |
| US3705946A (en) * | 1971-05-25 | 1972-12-12 | Lilly Co Eli | Method of treating hyperuricemia |
| US3880995A (en) * | 1973-05-14 | 1975-04-29 | Lilly Co Eli | Treatment of arthritis with mycophenolic acid and derivatives |
| JPS56127093A (en) * | 1980-03-10 | 1981-10-05 | Ajinomoto Co Inc | Preparation of mycophenolic acid |
| US4959387A (en) * | 1986-01-23 | 1990-09-25 | Syntex (U.S.A.) Inc. | Mycophenolic acid derivatives in the treatment of rheumatoid arthritis |
| US4725622A (en) * | 1986-01-23 | 1988-02-16 | Syntex (U.S.A.) Inc. | Mycophenolic acid derivatives in the treatment of rheumatoid arthritis |
| US5177072A (en) * | 1987-01-30 | 1993-01-05 | Syntex (U.S.A.) Inc. | Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives |
| US4748173A (en) * | 1987-01-30 | 1988-05-31 | Syntex (U.S.A.) Inc. | Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions |
| US4753935A (en) * | 1987-01-30 | 1988-06-28 | Syntex (U.S.A.) Inc. | Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions |
| WO1994012184A1 (en) * | 1992-11-24 | 1994-06-09 | Syntex (U.S.A.) Inc. | Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis |
| AU3178293A (en) * | 1992-11-24 | 1994-06-22 | Syntex (U.S.A.) Inc. | Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis |
| US5651983A (en) * | 1993-02-26 | 1997-07-29 | The Procter & Gamble Company | Bisacodyl dosage form for colonic delivery |
| CZ286051B6 (cs) * | 1993-02-26 | 1999-12-15 | The Procter & Gamble Company | Farmaceutický prostředek a způsob jeho použití pro dasažení projímavého účinku |
| US5843479A (en) * | 1993-02-26 | 1998-12-01 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| US5656290A (en) * | 1993-02-26 | 1997-08-12 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| US5455045A (en) * | 1993-05-13 | 1995-10-03 | Syntex (U.S.A.) Inc. | High dose formulations |
| HU228672B1 (en) * | 1993-10-01 | 2013-05-28 | Syntex Inc | Mycophenolate mofetil high dose oral suspensions and process for preparing them |
| WO1995011024A1 (en) * | 1993-10-19 | 1995-04-27 | The Procter & Gamble Company | Picosulphate dosage form |
| US5514663A (en) * | 1993-10-19 | 1996-05-07 | The Procter & Gamble Company | Senna dosage form |
| US5482718A (en) * | 1994-03-23 | 1996-01-09 | Hoffmann-La Roche Inc. | Colon-targeted delivery system |
| US5686106A (en) * | 1995-05-17 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form for colonic delivery |
| ID18663A (id) * | 1996-04-12 | 1998-04-30 | Novartis Ag | Komposisi farmasi berlapis enterik |
| DE60044717D1 (de) * | 1999-05-10 | 2010-09-02 | Paolo Brenner | Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen |
| HUP9903226A2 (en) * | 1999-09-23 | 2002-08-28 | Gyogyszerki | Process for producing mycophenolic acid and derivatives thereof |
| CZ20022913A3 (cs) * | 2000-02-29 | 2003-02-12 | Biocon India Limited | Výroba a čištění kyseliny mykofenolové |
| GB0124953D0 (en) | 2001-10-17 | 2001-12-05 | Novartis Ag | Organic Compounds |
| GB0301259D0 (en) | 2003-01-20 | 2003-02-19 | Novartis Ag | Organic compounds |
-
2001
- 2001-10-17 GB GBGB0124953.1A patent/GB0124953D0/en not_active Ceased
-
2002
- 2002-10-15 PE PE2002001013A patent/PE20030476A1/es not_active Application Discontinuation
- 2002-10-15 TW TW091123694A patent/TWI333861B/zh not_active IP Right Cessation
- 2002-10-15 CO CO02092380A patent/CO5390076A1/es not_active Application Discontinuation
- 2002-10-15 AR ARP020103852A patent/AR036813A1/es not_active Application Discontinuation
- 2002-10-16 KR KR1020047005588A patent/KR100671367B1/ko not_active Ceased
- 2002-10-16 PL PL367738A patent/PL234541B1/pl unknown
- 2002-10-16 AU AU2002338897A patent/AU2002338897B2/en not_active Expired
- 2002-10-16 DE DE60222687.2T patent/DE60222687T3/de not_active Expired - Lifetime
- 2002-10-16 JP JP2003535782A patent/JP2005508959A/ja active Pending
- 2002-10-16 NZ NZ532280A patent/NZ532280A/en not_active IP Right Cessation
- 2002-10-16 ES ES02777314T patent/ES2292819T5/es not_active Expired - Lifetime
- 2002-10-16 EP EP02777314.2A patent/EP1438040B2/en not_active Expired - Lifetime
- 2002-10-16 WO PCT/EP2002/011589 patent/WO2003032978A1/en not_active Ceased
- 2002-10-16 US US10/492,289 patent/US20050013859A1/en not_active Abandoned
- 2002-10-16 CA CA002460574A patent/CA2460574A1/en not_active Abandoned
- 2002-10-16 IL IL16096802A patent/IL160968A0/xx unknown
- 2002-10-16 AT AT02777314T patent/ATE374023T1/de active
- 2002-10-16 RU RU2004115332/15A patent/RU2338528C2/ru not_active IP Right Cessation
- 2002-10-16 PL PL415001A patent/PL415001A1/pl unknown
- 2002-10-16 SI SI200230646T patent/SI1438040T2/sl unknown
- 2002-10-16 MY MYPI20023865A patent/MY139206A/en unknown
- 2002-10-16 CN CNB028198611A patent/CN1310640C/zh not_active Expired - Fee Related
- 2002-10-16 DK DK02777314.2T patent/DK1438040T4/da active
- 2002-10-16 PT PT02777314T patent/PT1438040E/pt unknown
- 2002-10-16 HU HU0600451A patent/HU231114B1/hu unknown
- 2002-10-16 BR BRPI0213355-5A patent/BR0213355A/pt active Search and Examination
- 2002-10-16 MX MXPA04003636A patent/MXPA04003636A/es active IP Right Grant
- 2002-11-19 EC EC2002004341A patent/ECSP024341A/es unknown
- 2002-11-19 EC EC2002004342A patent/ECSP024342A/es unknown
-
2004
- 2004-03-11 ZA ZA200401977A patent/ZA200401977B/en unknown
- 2004-03-18 IL IL160968A patent/IL160968A/en active IP Right Grant
- 2004-05-03 NO NO20041785A patent/NO341804B1/no not_active IP Right Cessation
-
2007
- 2007-08-13 RU RU2007130786/15A patent/RU2381026C2/ru not_active IP Right Cessation
- 2007-12-19 CY CY20071101618T patent/CY1107841T1/el unknown
-
2009
- 2009-01-23 JP JP2009012781A patent/JP2009137996A/ja active Pending
-
2010
- 2010-05-03 US US12/772,608 patent/US20100210717A1/en not_active Abandoned
-
2012
- 2012-05-04 AR ARP120101574A patent/AR085778A2/es not_active Application Discontinuation
- 2012-05-29 US US13/482,003 patent/US20120237601A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508959A5 (cg-RX-API-DMAC7.html) | ||
| CA2348086C (en) | Controlled-release pharmaceutical formulations | |
| KR101563390B1 (ko) | 감마-하이드록시부티르산을 주성분으로 하는 신규 조성물 | |
| RU2004115332A (ru) | Фармацевтические композиции, содержащие микрофенольную кислоту или соль (микофенолят) | |
| FI92904C (fi) | Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi | |
| JP2009545560A5 (cg-RX-API-DMAC7.html) | ||
| JP2007506766A5 (cg-RX-API-DMAC7.html) | ||
| EA023532B1 (ru) | Флотирующие микрогранулы | |
| RU99126869A (ru) | Фармацевтический препарат омепразола | |
| UA69396C2 (uk) | ПЕРОРАЛЬНА ДОЗОВАНА ФАРМАЦЕВТИЧНА ФОРМА З ДИСКРЕТНИМ ВИВІЛЬНЕННЯМ ІНГІБІТОРА Н<sup>+</sup>,К<sup>+</sup>,-АТФ-АЗИ (ВАРІАНТИ) ТА СПОСІБ ЇЇ ОДЕРЖАННЯ (ВАРІАНТИ) І СПОСІБ ЛІКУВАННЯ (ВАРІАНТИ) | |
| CA2670690C (en) | Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid | |
| RU2008106220A (ru) | Гастроретентивные композиции и способ их изготовления | |
| RU2006139000A (ru) | Диспергирующиеся таблетки деферасирокса | |
| ITMI941262A1 (it) | Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo | |
| KR20130103384A (ko) | 클로피도그렐과 아스피린을 포함하는 약학 조성물 및 그의 제조방법 | |
| CN101804030A (zh) | 一种双氯芬酸钠微丸制剂及其制备方法 | |
| JPS59155312A (ja) | 新規薬理製剤 | |
| CA2461576A1 (en) | Process for the preparation of tablets comprising s-adenosylmethionine | |
| JP3836528B2 (ja) | イブプロフェン含有錠剤及びその製造法 | |
| US20110280945A1 (en) | Novel method for the preparation of granulates of active constituents, and granulates as obtained | |
| JPH05255088A (ja) | 抗潰瘍剤含有製剤 | |
| JPH0733659A (ja) | 抗潰瘍剤含有製剤 | |
| JP2002518334A5 (cg-RX-API-DMAC7.html) | ||
| WO2013095316A1 (en) | Synergic combination comprising anti-diabetic agent | |
| WO2003094899A1 (es) | Nuevo procedimiento para la preparacion de composiciones de liberacion programada conteniendo (s) -1- [n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-proline, y al producto obtenido por dicho procedimiento |